MINDY WENGER: Open Payments
NPI 1982784559 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 73 payments from 19 companies in 2025. Trend: 2023 $730 · 2024 $1,455 · 2025 $1,354
Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $356 |
| Amgen Inc. | 7 | $112 |
| ABBVIE INC. | 6 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $102 |
| Corcept Therapeutics | 4 | $92 |
| PFIZER INC. | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Abbott Laboratories | 3 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
Products named: Rybelsus, Wegovy, Kerendia, Korlym, JARDIANCE, NURTEC ODT, FREESTYLE LIBRE 3, FARXIGA.
Industry payments across TN — which companies pay providers there.
